Accolades
Sidley Named “Law Firm of the Year” in FDA Law and Securities Regulation by Best Lawyers
November 3, 2023
The 2024 edition of Best Lawyers’ “Best Law Firms” honored Sidley with its “Law Firm of the Year” designation in two U.S. national categories:
- FDA Law
- Securities Regulation
Every year, one standout law firm is designated as the “Law Firm of the Year” in each national category. Notably, Sidley has won in both categories in multiple editions, having won in FDA Law in the 2022 and 2020 editions, and in Securities Regulation in the 2020, 2017, and 2012 editions.
Capabilities
Suggested News & Insights
GMP 2026: Regulatory Reliance, AI, and the Future of Pharmaceutical ManufacturingWednesday, December 2, 2026FDA Announces Rare Disease Framework Initiative to Foster Consistent Review Approach Tailored to Unique Drug Development Considerations for Rare DiseasesOctober 20, 2026Sidley Represents Strategic Partnership Between Silgan and AIP in US$7.3 Billion Transaction to Create Diversified Global Metal Packaging BusinessOctober 19, 20262026 Momentum Food and Beverage ExchangeOctober 6-7, 2026Sidley Represents GE HealthCare in Its US$945 Million Acquisition of SOFIE BiosciencesOctober 7, 2026Sidley Represents Telix Pharmaceuticals in Its US$1.65 Billion Merger With ITMOctober 5, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory